1. Introduction {#s0005}
===============

Leishmaniasis is a vector-borne disease which is transmitted by sandflies. It is caused by about 20 different species of the genus *Leishmania* ([@b0035]). This disease has a wide range of clinical symptoms that ranges from self-healing ulcers, which is called cutaneous leishmaniasis, to progressive nasopharyngeal infections (mucocutaneous leishmaniasis) and fatal disseminating visceral leishmaniasis ([@b0005]). Due to the occurrence of visceral leishmaniasis as an opportunistic infection in HIV-infected patients, the expansion of the AIDS pandemic makes the emergence of leishmaniasis/HIV co-infection a serious problem ([@b0075]). Since long time attention was paid toward the promising potential of medicinal plants for treatment of prevailing ailments. Moreover, the high cost and limited availability of effective pharmaceutical products suggest the use of native plants for symptomatic treatment of leishmaniasis in areas where it is endemic. In traditional medicine, the treatment of this disease usually consists of oral administration of crude plant extracts for visceral leishmaniasis, and topical preparations for the treatment of skin infections ([@b0020]).

The genus *Euphorbia* comprises the largest among genera of the family Euphorbiaceae. It includes about 1600 known species ([@b0010]), ranging from annuals to trees; all contain latex and have unique flower structure. Some of the reported folk medicinal uses of *Euphorbia* include treatment of skin diseases, gonorrhea, migraines, intestinal parasites, and warts ([@b0050]). In Iran some species are used as purgative ([@b0085]). In addition, different species of *Euphorbia* contain macrocyclic diterpenoids with antibacterial, anticancer, PGE2-inhibitory, anti-HIV, and analgesic activity ([@b0050]). *Euphorbia peplus* L. is originally native to Europe and North Africa ([@b0090]). The plant has a milky sap that is used in traditional medicine for treatment of non-melanoma skin cancer; the active compounds have been determined to be diterpene esters ([@b0070]). In our search for leishmanicidal secondary metabolites, twenty extracts from fifteen plants growing in Egypt have been investigated for *in vitro* leishmanicidal activity against *Leishmania donovani* promastigotes. Among the tested extracts, the methanol extract of *E. peplus* aerial part exhibited a powerful leishmanicidal activity. Moreover, biologically-guided isolation of four compounds from the aerial parts of *E. peplus* is presented.

2. Materials and methods {#s0010}
========================

2.1. General experimental {#s0015}
-------------------------

1D and 2D NMR spectra were recorded on a Bruker Avance III 400 MHz with BBFO Smart Probe and Bruker 400 MHz AEON Nitrogen-Free Magnet (Bruker AG, Switzerland) using the chemical shift of CDCl~3~ solvent peak at 7.24 (s) ppm in ^1^H and 77.2 (t) ppm in ^13^C NMR as an internal reference standard. Data were analyzed using Topspin 3.1 Software. LC-ESIMS was obtained using a Bruker Bio Apex FT-MS in ESI mode.

2.2. Material for chromatography {#s0020}
--------------------------------

Thin layer chromatography (TLC), pre-coated silica gel 60 F~254~ plates (Fisher Scientific, Suwanee, GA) for TLC; developing system: *n*-hexane-EtOAc (8:2 and 7:3) and visualization using 10% H~2~SO~4~ in MeOH. Column chromatography (CC) was performed with silica gel (230--400 mesh) and Sephadex LH-20 (Pharmacia Biotech, Uppsala).

2.3. Plant materials {#s0025}
--------------------

All plant materials were collected in Egypt and were identified by Dr. M. Elgebaly, Faculty of Science, Cairo University. Botanical names and plant parts are listed in [Table 1](#t0005){ref-type="table"}. Voucher samples were deposited in the Pharmacognosy Department, Faculty of Pharmacy, Beni-Suef University, with voucher numbers listed in [Table 1](#t0005){ref-type="table"}. *E. peplus* L. was collected on March, 2013, from El-Nil public garden, Beni-Suef, Egypt.

2.4. Extraction {#s0030}
---------------

The collected samples (200 g each) were dried under controlled temperature not exceeding 45 °C, pulverized and then extracted with 80% methanol (300 ml × 3) by percolation. The extracts were then dried under reduced pressure at temperature not exceeding 45 °C. Preliminary testing of the prepared extracts used for antileishmanial activity against the protozoan *L. donovani* (National Center for Natural Products Research NCNPR, University of Mississippi, Oxford, MS, USA), revealed significant activity for the alcohol extract of *E. peplus* (Family Euphorbiaceae). The air-dried aerial part of *E. peplus* (1 kg) was pulverized using a laboratory mill and extracted with 80% methanol (5L × 5). The methanol was removed by vacuum distillation to give (100 g) residue. Successive fractionation using solvents of different polarities such as *n*-hexane, DCM and EtOAc was done, then the fractions were subjected to antileishmanial screening. The *n*-hexane fraction was the most active ([Fig. 1](#f0005){ref-type="fig"}).

2.5. Chromatographic isolation {#s0035}
------------------------------

Hexane fraction (25 g) was subjected to CC over silica gel for column (200 g, 4 cm × 65 cm) using gradient elution starting with pet. ether-DCM till 100% DCM then adding EtOAc in 5% increments. Seven collective fractions were obtained after TLC monitoring. Column subfractions were subjected to primary antileishmanial screening, and three fractions were found active as shown in [Fig. 1](#f0005){ref-type="fig"}. Fraction 3 (eluted with 50% DCM in pet. ether) was rechromatographed over silica gel eluted with pet. ether-EtOAc in 5% increments to get compound **1** (25 mg) and another sub-fraction that was rechromatographed over Sephadex-LH-20 eluted with DCM-MeOH (80:20) to get compound **2** (63 mg). Fraction 4 (eluted with 75% DCM in pet. ether) was rechromatographed using silica gel column and isocratic elution with 10% EtOAc in pet. ether to get compound **3** (12 mg). Fraction 7 (eluted with 100% EtOAc) was rechromatographed on silica gel column eluted with DCM-MeOH in a gradient fashion to give compound **4** (18 mg) (see [Fig. 2](#f0010){ref-type="fig"}).

2.6. Characterization of the isolated compounds {#s0040}
-----------------------------------------------

***Compound (1)**:*** **Simiarenol:** ESIMS showed \[M+1\]^+^ at *m*/*z* 427.1743 indicating a molecular formula of C~30~H~50~O. ^1^H NMR (400 MHz, CDCl~3~): *δ* 5.64 (d, *J* = 5.0 Hz, 1H), 3.50 (m, 1H), 2.18--1.18 (m, 24H), 1.16 (s, 3H), 1.07 (s, 3H), 1.03 (s, 3H), 0.95 (s, 3H), 0.92 (s, 3H), 0.91 (overlapped d, 3H), 0.85 (overlapped d, 3H), 0.80 (s, 3H). ^13^C NMR (100 MHz, CDCl~3~): *δ* 142.0, 122.0, 76.4, 60.1, 51.8, 50.9, 50.3, 44.3, 42.8, 40.8, 39.3, 38.6, 35.4, 34.8, 34.2, 30.8, 29.1, 29.0, 28.3, 27.8, 25.5, 24.1, 22.9, 21.9, 19.9, 18.1, 17.9, 16.1, 15.8, 15.0. NMR data were consistent with the literature ([@b0030]).

***Compound (2)**:*** **1-Hexacosanol:** ESIMS showed \[M+1\]^+^ at *m*/*z* 383.2057 indicating a molecular formula of C~26~H~54~O. ^13^C NMR (CDCl~3~, 100 MHz): *δ*~C~ 63.1 (CH~2~-OH), 32.7 (CH~2~), 31.9 (CH~2~), 29.4 (CH~2~), 29.3 (CH~2~), 29.2 (CH~2~), 25.4 (CH~2~), 22.7 (CH~2~), 14.2 (CH~3~) indicating unsaturated primary fatty alcohol. ^13^C NMR data were consistent with fatty alcohols ([@b0065]).

***Compound (3)**:*** **β-sitosterol:** ESIMS showed \[M+1\]^+^ at *m*/*z* 415.2953 indicating a molecular formula C~29~H~50~O. ^13^C NMR (100 MHz, CDCl~3~) *δ* 140.77, 121.72, 71.81, 56.78, 56.06, 50.14, 45.84, 42.33, 42.31, 39.78, 37.26, 36.51, 36.15, 33.95, 31.91, 31.67, 29.16, 28.25, 26.08, 24.31, 23.07, 21.09, 19.82, 19.40, 19.04, 18.79, 11.99, 11.86. Data were consistent with previously published data ([@b0055]).

***Compound (4)**:*** **β-sitosterol-3-*O*-glucoside:** ESIMS spectrum showed an M^+^ at *m*/*z* 576.4 and for the aglycon β-sitosterol at *m*/*z* 414.4. CO-TLC with authentic sample using CHCl~3~-MeOH (8:2) confirmed the identification of compound **4** as β-sitosterol-3-*O*-glucoside.

2.7. Assay for leishmanicidal activity {#s0045}
--------------------------------------

Antileishmanial activity was tested *in vitro* on a culture of *L. donovani* promastigotes. In a 96-well micro plate assay appropriately diluted extracts were added to the leishmania promastigotes culture (2 × 10^6^ cells mL^−1^). The plates were incubated at 26 °C for 72 h and growth of *Leishmania* promastigotes was determined by use of the Alamar blue assay ([@b0060]). Standard fluorescence was measured by a Fluostar Galaxy plate reader (excitation wavelength: 544 nm; emission wavelength: 590 nm). Pentamidine (IC~50~ 1.01 and IC~90~ 2.03 μg/mL) and amphotericin B (IC~50~ 0.47 and IC~90~ 0.65) were used as the drug controls. Percent growth was calculated and plotted against the tested concentrations to determine the IC~50~ and IC~90~ values.

3. Results and discussion {#s0050}
=========================

Fifteen plants related to the families Acanthaceae, Aizoaceae, Asteraceae, Brassicaceae, Chenopodiaceae, Euphorbiaceae, Gramineae, Solanaceae and Zygophyllaceae ([Table 1](#t0005){ref-type="table"}) were tested for leishmanicidal activity against *L. donovani* promastigotes. Among the tested extracts, the methanolic extract of *E. peplus* showed 100% growth inhibition with activity similar to amphotericin B. The methanolic extract was fractionated using *n*-hexane, DCM, and EtOAc and these fractions were subjected to rescreening as *L. Donovani* promastigotes growth inhibitor. The *n*-hexane fraction showed 75% inhibition ([Fig. 1](#f0005){ref-type="fig"}). Hexane fraction was subjected to VLC fractionation and the sub-fractions were screened for antileishmanial activity. Three fractions were found active (IC~50~ = 20.24, 34.87, 32.05 μg/ml) and the other fractions showed activity at \>40 μg/ml and considered inactive. The active fractions were analyzed using HPLC/HRMS in addition to chromatographic isolation of four known compounds elucidated as simiarenol **(1),** 1-hexacosanol **(2)**, β-sitosterol **(3)**, and β-sitosterol-3-*O*-glucoside **(4).**

The total methanolic extract showed 100% inhibition of growth with activity similar to amphotericin B. Upon fractionation, the *n*-hexane fraction showed 75% inhibition and then the *n*-hexane subfractions showed activity with IC~50~ = 20.24, 34.87, 32.05 μg/ml and IC~90~ \> 40 μg/ml compared to pentamidine (IC~50~ = 1.01 and IC~90~ = 2.03 μg/ml) and amphotericin B (IC~50~ = 0.47 and IC~90~ = 0.65 μg/ml) which indicated synergistic effect of secondary metabolites in *E. peplus* total methanolic extract with special concentration in the *n*-hexane fraction.

Although the isolated compounds were previously reported in the title plant, the result of their presence in the active antileishmanial fractions adds to their biologic importance. Compound **1** was assigned to be 5-adianene-3-β-ol which is commonly named as simiarenol. Simiarenol was first isolated from *Rhododendron simiarum* ([@b0015]). It was previously isolated from *Euphorbia lagascae* and *Euphorbia tuckeyana* ([@b0030]) as well as detected in the epicuticular leaf waxes from *Euphorbia characias*, *Euphorbia nicaeensis*, *E. peplus* ([@b0040]) and *Euphorbia lathyris* ([@b0045]).

Compound **2** was a saturated fatty alcohol (1-hexacosanol). Fatty acids and alcohols exhibit antimicrobial effects as they can prevent the growth of or directly kill bacteria, fungi and other microbes by affecting multiple cellular targets, including the cell membrane ([@b0025]).

The inhibiting activity of some triterpenes and sterols for promastigotes and intracellular amastigotes of *Leishmania amanuensis* was previously reported but β-sitosterol was inactive against this species ([@b0080]), and we reported here the activity of β-sitosterol (**3**) and its 3-*O*-glucoside derivative (**4**) toward *L. donovani* promastigotes.

In conclusion, many of non-polar components in *E. peplus* exhibited synergistic effect to produce leishmanicidal activity against *L. donovani* promastigotes. So far, it is the first report of these compounds to such activity that may be helpful in future to include the *n*-hexane extract in food supplements for treatment of different leishmaniasis caused by such pathogen.
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![Scheme for biologically-guided isolation of secondary metabolites from *Euphorbia peplus* aerial parts.](gr1){#f0005}

![Compounds isolated from *Euphorbia peplus* aerial part.](gr2){#f0010}

###### 

Plant list and their primary antileishmanial screening result.

  Family and plant name (voucher no.)         Part used     \% of inhibition
  ------------------------------------------- ------------- ------------------
  *Acanthaceae*                                             
  *Adhatoda vasica* (BUPD-45)                 Leaf          45
  Stem                                        14            
                                                            
  *Aizoaceae*                                               
  *Mesembryanthemum crystallinum* (BUPD-22)   Aerial part   0
  *Mesembryanthemum forsskaolii* (BUPD-21)    Aerial part   14
  *Aizoon canariensis* (BUPD-46)              Aerial part   17
  *Trianthemum portulacastrum* (BUPD-47)      Aerial part   20
                                                            
  *Asteraceae*                                              
  *Tagetes patula* (BUPD-48)                  Leaf          12
  Stem                                        10            
  Flower                                      15            
                                                            
  *Brassicaceae*                                            
  *Brassica rapa rapa* (BUPD-49)              Aerial part   8
                                                            
  *Chenopodiaceae*                                          
  *Anabasis setifera* (BUPD-50)               Aerial part   5
  *Atriplex lindleyi* (BUPD-51)               Aerial part   6
                                                            
  *Euphorbiaceae*                                           
  *Euphorbia helioscopia* (BUPD-52)           Aerial part   48
  *Euphorbia peplus* (BUPD-53)                Aerial part   100
                                                            
  *Gramineae*                                               
  *Sorghum bicolor* (BUPD-54)                 Seedlings     19
                                                            
  *Solanaceae*                                              
  *Solanum nigrum* (BUPD-55)                  Leaf          14
  Stem                                        14            
  Flower                                      18            
                                                            
  *Zygophyllaceae*                                          
  *Zygophyllum coccineum* (BUPD-56)           Aerial part   14
  *Zygophyllum decumbens* (BUPD-57)           Aerial part   6
